Oruka Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-25-050756 | Jun 3, 2025 | Jun 2, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-010822 | Jun 3, 2025 | Jun 2, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-010826 | Jun 3, 2025 | Jun 2, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-010825 | Jun 3, 2025 | Jun 2, 2025 |
| SCHEDULE 13G | — | 0000950170-25-072013 | May 15, 2025 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-043374 | May 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043279 | May 14, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001172661-25-001776 | May 13, 2025 | — |
| ARS | ANNUAL REPORT | 0001213900-25-033326 | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-033322 | Apr 18, 2025 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-25-033316 | Apr 18, 2025 | Jun 2, 2025 |
| EFFECT | — | 9999999995-25-000640 | Mar 11, 2025 | — |
| SCHEDULE 13D/A | — | 0001213900-25-022364 | Mar 10, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-021165 | Mar 6, 2025 | Dec 31, 2024 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-021200 | Mar 6, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-021251 | Mar 6, 2025 | — |
| 4 | — | 0001415889-25-005908 | Feb 27, 2025 | Feb 10, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-005913 | Feb 27, 2025 | — |
| 3 | — | 0001415889-25-005906 | Feb 27, 2025 | Feb 10, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-010525 | Feb 5, 2025 | Feb 4, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-001087 | Jan 24, 2025 | Jan 22, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-001088 | Jan 24, 2025 | Jan 22, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-001089 | Jan 24, 2025 | Jan 22, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-001085 | Jan 24, 2025 | Jan 22, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-110303 | Dec 19, 2024 | Dec 17, 2024 |
| EFFECT | — | 9999999995-24-003588 | Nov 26, 2024 | — |
| UPLOAD | — | 0000000000-24-012994 | Nov 22, 2024 | — |
| CORRESP | — | 0001213900-24-101587 | Nov 22, 2024 | — |
| 4 | — | 0001213900-24-101116 | Nov 21, 2024 | Nov 19, 2024 |
| SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 0001213900-24-101117 | Nov 21, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-099645 | Nov 18, 2024 | Nov 14, 2024 |
| SC 13G/A | JANUS CLOSEOUT | 0001274173-24-000089 | Nov 14, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-098530 | Nov 14, 2024 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-098574 | Nov 14, 2024 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-24-097737 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119331 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001013594-24-000956 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000919574-24-006793 | Nov 14, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-097443 | Nov 13, 2024 | Sep 30, 2024 |
| SC 13D/A | — | 0000902664-24-005943 | Oct 22, 2024 | — |
| DEF 14A | DEF 14A | 0001140361-24-043698 | Oct 18, 2024 | Nov 14, 2024 |
| PRE 14A | PRE 14A | 0001140361-24-042965 | Oct 7, 2024 | Nov 14, 2024 |
| SC 13G | — | 0000315066-24-002024 | Oct 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-085543 | Oct 4, 2024 | Oct 3, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-078549 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | — | 0001213900-24-078633 | Sep 13, 2024 | Sep 11, 2024 |
| SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001213900-24-078635 | Sep 13, 2024 | — |
| 3 | — | 0001213900-24-076588 | Sep 6, 2024 | Aug 29, 2024 |
| 3 | — | 0001213900-24-076589 | Sep 6, 2024 | Aug 29, 2024 |
| 3 | — | 0001213900-24-076591 | Sep 6, 2024 | Aug 29, 2024 |